Market Research Logo

Cardiovascular Systems Inc (CSII) - Product Pipeline Analysis, 2018 Update

Summary

Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Cardiovascular Systems Inc Company Overview
Cardiovascular Systems Inc Company Snapshot Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview Cardiovascular Systems Inc – Pipeline Analysis Overview Cardiovascular Systems Inc - Key Facts Cardiovascular Systems Inc - Major Products and Services Cardiovascular Systems Inc Pipeline Products by Development Stage Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status Cardiovascular Systems Inc Pipeline Products Overview Diamondback 360 Peripheral Orbital Atherectomy System Diamondback 360 Peripheral Orbital Atherectomy System Product Overview Diamondback 360 Peripheral Orbital Atherectomy System Clinical Trial Second Generation Diamondback 360 Coronary Orbital Atherectomy System Second Generation Diamondback 360 Coronary Orbital Atherectomy System Product Overview Second Generation Diamondback 360 Coronary Orbital Atherectomy System Clinical Trial ZILIENT Guidewire - Coronary Intervention ZILIENT Guidewire - Coronary Intervention Product Overview ZILIENT Guidewire - Radial Peripheral Intervention ZILIENT Guidewire - Radial Peripheral Intervention Product Overview Cardiovascular Systems Inc - Key Competitors Cardiovascular Systems Inc - Key Employees Cardiovascular Systems Inc - Locations And Subsidiaries Head Office Recent Developments Cardiovascular Systems Inc, Recent Developments Jul 16, 2018: Cardiovascular Systems Signs International Distribution Agreement with OrbusNeich May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Financial Results Mar 06, 2018: Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes at CRT18 Interventional Cardiology Conference Feb 26, 2018: Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX AR-V7 Nucleus Detect Test to Predict Treatment Response in Metastatic Disease Feb 23, 2018: Holy Cross Hospital is One of the First to Use New DIAMONDBACK 360 CORONARY OAS Technology for Treatment of Coronary Artery Disease Feb 16, 2018: QSpine Receives CE Mark Certification for SURE Single Use Illuminated Retractor System Feb 14, 2018: Cardiovascular Systems Announces First Patients Treated from Radial Access Using Its Diamondback 360 Extended Length Peripheral Orbital Atherectomy Device Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer Feb 01, 2018: Cardiovascular Systems Announces Commercial Launch in Japan
Appendix
Methodology About GlobalData Contact Us Disclaimer
List of Tables
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
Cardiovascular Systems Inc Pipeline Products by Equipment Type
Cardiovascular Systems Inc Pipeline Products by Indication
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc, Key Facts
Cardiovascular Systems Inc, Major Products and Services
Cardiovascular Systems Inc Number of Pipeline Products by Development Stage
Cardiovascular Systems Inc Pipeline Products Summary by Development Stage
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc Ongoing Clinical Trials Summary
Diamondback 360 Peripheral Orbital Atherectomy System - Product Status
Diamondback 360 Peripheral Orbital Atherectomy System - Product Description
Diamondback 360 Peripheral Orbital Atherectomy System - Diamondback Atherectomy with OCT Visualization for Calcified PAD Lesions for Calcified Peripheral Vascular Disease Lesions
Diamondback 360 Peripheral Orbital Atherectomy System - Directional Versus Orbital Atherectomy Plaque Modification and Luminal Area Assessment of the Femoro-popliteal Artery Via Intravascular Ultrasound
Diamondback 360 Peripheral Orbital Atherectomy System - Orbital Vessel Preparation to Maximize DCB Efficacy in Calcified below the Knee (BTK) Lesions - A Pilot Study
Diamondback 360 Peripheral Orbital Atherectomy System - Prospective, Observational, Multi-center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients with Distal Outflow Peripheral Arterial Disease (PAD): LIBERTY 360
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Product Status
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Product Description
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Comparison of Orbital Versus Rotational Atherectomy Effects on Coronary Microcirculation in Percutaneous Coronary Intervention (PCI)
Second Generation Diamondback 360 Coronary Orbital Atherectomy System - Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial
ZILIENT Guidewire - Coronary Intervention - Product Status
ZILIENT Guidewire - Coronary Intervention - Product Description
ZILIENT Guidewire - Radial Peripheral Intervention - Product Status
ZILIENT Guidewire - Radial Peripheral Intervention - Product Description
Cardiovascular Systems Inc, Key Employees
Glossary
List of Figures
Cardiovascular Systems Inc Pipeline Products by Equipment Type
Cardiovascular Systems Inc Pipeline Products by Development Stage
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report